NeoGenomics Stock Falls Over 12% Following Leadership Changes
NeoGenomics (NEO) experienced a significant drop in stock price, falling more than 12% on Tuesday. This marks its worst one-day decline in over a year. The downturn followed the company's announcement of leadership changes and a preannouncement of its Q3 2026 results. The leadership transition appears to have raised concerns among investors about potential instability or uncertainty regarding future performance, contributing to the sharp drop in share value.
Tickers: $NEO
Topics: earnings preannouncement leadership changes stock decline